U.S. Must Do More to Protect Deployed Forces

It's been a decade since the Persian Gulf War. But the controversy continues over whether the long-term health problems of some Gulf War veterans were caused by exposure to chemical warfare agents and other hazardous materials. Unfortunately for many veterans and their families, it may never be settled definitively. Despite numerous studies that have investigated the issue, there is not enough evidence to link long-term health problems with exposures to certain drugs, chemicals, and vaccines kno

Written byMoxley Iii
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

It's been a decade since the Persian Gulf War. But the controversy continues over whether the long-term health problems of some Gulf War veterans were caused by exposure to chemical warfare agents and other hazardous materials. Unfortunately for many veterans and their families, it may never be settled definitively. Despite numerous studies that have investigated the issue, there is not enough evidence to link long-term health problems with exposures to certain drugs, chemicals, and vaccines known to be present during the Gulf War. That's largely because few data are available on the levels of harmful substances to which troops may have been exposed--a critical factor in assessing health effects.

The U.S. military's experience in the Gulf and other deployments sharply illustrates the importance of anticipating and monitoring the potential exposure of troops to hazardous materials in the field. And yet, 10 years later, the Department of Defense (DOD) has made ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies